Skip to content

Scrutinizing the (in)efficient use of cholecystectomy.

Scrutinizing the (in)efficient use of cholecystectomy: a randomized trial concerning variation in practice

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
NL-OMON
Registry ID
NL-OMON27558
Enrollment
986
Registered
2013-06-05
Start date
2013-07-01
Completion date
Unknown
Last updated
2024-02-28

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Cholecystectomy, gallstones, randomized trial, variation in practice Cholecystectomie, galstenen, praktijkvariatie, gerandomiseerde studie.

Interventions

The intervention includes a standardized work-up and multistage selection for cholecystectomy. Standardization is done by strict administration of the symptoms associated with symptomatic cholecystoli

Sponsors

Academisch Medisch Centrum
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1. Having abdominal symptoms and having ultrasound proven gallstones or sludge (proven before or after referral); 2. Being referred to a surgeon for the treatment of suspected symptomatic gallstone disease; 3. Aged 18 years or older; 4. Providing informed consent.

Exclusion criteria

Exclusion criteria: 1. History of complicated cholelithiasis (i.e. choledocholithiasis, acute cholecystitis, biliary pancreatitis or cholangitis) since these types of patients are scheduled for elective cholecystectomy to prevent recurrence of complicated cholelithiasis rather than to prevent complaints of symptomatic cholecystolithiasis; 2. Indication for primary open cholecystectomy; 3. History of current malignancy; 4. Expected short life span of less than 12 months; 5. Suffering from severe or life-threatening systemic diseases (American Society of Anesthesiologists (ASA) class III and IV); 6. Known cirrhosis of the liver; 7. Current schizophrenia, memory deficiency, or any other disorder that predispose them to unreliable questionnaire responses; 8. Mentally incompetent; 9. Insufficient knowledge of the Dutch language; 10. Unable to read due to blindness; 11. Known pregnancy; 12. Residence in a federal correctional institution.

Design outcomes

Primary

MeasureTime frame
The proportion of patients being pain free at 12 months of follow-up. Pain free is defined as a visual analogue scale (VAS; validated pain score) less than or equal to 4 over the last two weeks before evaluation.

Secondary

MeasureTime frame
1. The proportion of patients being pain-free after cholecystectomy; 2. The proportion of cholecystectomies; 3. The proportion of patients with complications (i.e. choledocholithiasis, acute cholecystitis, biliary pancreatitis or cholangitis) due to gallstones; 4. Changes in health status and valuation over time. Health status will be measured using generic and disease specific health status questionnaires after informed consent and after 3, 6 and 12 months; 5. Time to pain free; 6. The relation between the patients’ symptoms and treatment and work performance as reported in the Health and Labour questionnaire; 7. Cost-effectiveness; 8. The proportion of complications due to the cholecystectomy.

Contacts

Public ContactA.H. Dijk, van

Afdeling Chirurgie Kamer G4-144 Academisch Medisch Centrum Amsterdam Meibergdreef 9

a.h.vandijk@amc.nl

Outcome results

None listed

Source: NL-OMON (via WHO ICTRP)